Home/Pipeline/Recivit® (Fentanyl)

Recivit® (Fentanyl)

Severe Pain

ApprovedActive

Key Facts

Indication
Severe Pain
Phase
Approved
Status
Active
Company

About Ethypharm

Ethypharm is a France-based, private specialty pharma company with nearly five decades of operation, specializing in drug delivery and essential medicines. It has established a clear strategic focus on the Central Nervous System (CNS) for severe pain and addiction, and on Hospital Injectables, leveraging its manufacturing and commercial capabilities. The company is in a commercial, revenue-generating stage, actively growing its portfolio through in-licensing and geographic expansion, particularly in Europe's top five markets and China. Its business model is centered on developing, manufacturing, and commercializing therapeutics, with a stated ambition to address unmet needs in its core areas.

View full company profile

Other Severe Pain Drugs

DrugCompanyPhase
EnveltaVirpax PharmaceuticalsPreclinical
XTAMPZA ERCollegium PharmaceuticalMarketed
NUCYNTА / NUCIENTА ERCollegium PharmaceuticalMarketed
BELBUCACollegium PharmaceuticalMarketed